Prognostic factors in oligodendrogliomas are not well defined, even co
nsidering the labeling index of proliferation markers. As in other neu
roepithelial tumors, the difficulty in calculating cell loss may contr
ibute to this uncertainty. Proliferation markers Ki-67/MIB.1 and PCNA,
mitoses, apoptotic nuclei, p53 and bcl-2 expression were investigated
in 98 oligodendrogliomas. Apoptosis was assessed by the aspect of nuc
lei, by in situ end-labeling (ISEL) technique and by c-Jun immunohisto
chemical demonstration. The Bcl-2 also was immunohistochemically studi
ed for its anti-apoptotic role. Mitotic index (MI), labeling index (LI
) for MIB.1 and PCNA and apoptotic index (AI) were calculated and comp
ared among themselves and with histology and survival. It was found th
at AI correlated with MI (p = 0.001) and was significantly higher in a
naplastic than in classic oligodendrogliomas (p = 0.001). Apoptosis oc
curred only slightly more frequently in cases with high LIs for prolif
eration markers (MIB.1 and PCNA) (p = non-significant) and it was defi
nitely higher in p53-positive cases (p = 0.008). It did not correlate
with bcl-2 which was poorly expressed in oligodendrogliomas, with the
exception of cells with astrocytic features. Apoptotic index correlate
d very weakly with survival (p = 0.05); therefore, it cannot be consid
ered a highly reliable prognostic factor in oligodendrogliomas. (C) 19
97 Elsevier Science Ltd.